Dr. Paul Chapman on the Choice to Pursue Adjuvant Immunotherapy for Melanoma Patients

Dr. Paul Chapman on the Choice to Pursue Adjuvant Immunotherapy for Melanoma Patients

Publication date: Jun 18, 2019

Cancer Network spoke with Paul B. Chapman, MD, of Memorial Sloan Kettering Cancer Center, about pursuing adjuvant immunotherapy for patients with melanoma. (Source: CancerNetwork)

Concepts Keywords
Adjuvant Organizations
Immunotherapy Medicine
Kettering Adjuvant therapy
Melanoma Health
Melanoma
Upper East Side
Immunotherapy
Charles F. Kettering

Semantics

Type Source Name
disease DOID Cancer
disease MESH Cancer
pathway BSID Melanoma
disease DOID Melanoma
disease MESH Melanoma
gene UNIPROT RNF31

Similar

Leave a Comment

Your email address will not be published. Required fields are marked *